Actionable trade ideas with defined risk and time horizons.
Curated trade ideas across equities, options, and other instruments, featuring clear directional bias, time horizon, and risk considerations. Trade ideas are designed to align market context, technical structure, and risk management principles.
12,222 total articles
National Fuel Gas (NFG) offers conservative investors a mix of reliable dividend income and modest capital appreciation potential. Trading around $83.22, the company yields roughly 2.6%, trades at ~11.6x trailing earnings, and boasts a 56-year streak of dividend increases. We outline an actionable long trade with entry, stop and target suited to a …
Himax Technologies looks positioned to benefit from an upturn in automotive display spending and continued wins in AR/AI microdisplays. With a market cap of $2.37B, modest yield and active product ramps, we upgrade to Buy for a tactical swing trade: entry $14.00, stop $12.50, target $18.00 over the next 45 trading days.
Comcast is trading essentially at book value with a 5% dividend yield and strong free cash flow. A committed separation of NBCUniversal or a similar corporate action would likely re-rate the stock above current levels. This trade idea lays out a long position with clear entry, targets and stop, rooted in valuation, cash flow and catalysts tied to c…
Amazon is trading at ~$266 and carries a P/E near 20.6 with a market cap around $2.9 trillion. With accelerating AI adoption at AWS, renewed advertiser demand, and a still-resilient retail engine, the stock can re-rate toward $330 over the next 180 trading days. This trade idea lays out an entry, stop, target, catalysts, and balanced risks.
Baozun (BZUN) looks actionable on a tactical long after recent constructive company commentary and a compressing loss profile. The stock is cheap on valuation metrics, shows bullish technicals, and has enough short interest to amplify a squeeze. Trade with a defined entry at $3.25, stop at $2.85 and a first target at $4.20 for a mid-term swing (45 …
Modine has real exposure to the fast-growing data center cooling market and a freshly public narrative: a massive hyperscale deal plus a planned spinoff of lower-margin business. The shares have pulled back into the $180s after a run; this trade targets a re-rating into the low $200s over the next 11-45 trading days while keeping a strict stop to l…
Papa John’s (PZZA) looks fairly valued at about $23.72. The business carries stable franchise cash flows, a roughly $780m market cap and an attractive dividend yield near 7.8%, but low free cash flow relative to dividends and recent guidance disappointment create clear constraints. For risk-tolerant traders I outline a limited-size, mid-term swing …
VEPPANU's FDA approval and positive VERITAC-2 data materially derisks Arvinas' platform story. With a market cap near $600M and an EV of roughly $510M, Arvinas is priced like a small commercial-stage biotech but still carries development optionality (ARV-102 for LRRK2). I like the risk/reward from $9.24 with a 180-trading-day target of $16, provide…
Flotek (FTK) lost a major Puerto Rico contract, triggering litigation and heavy shorting, but the parts of the business that produce recurring revenue and margin expansion continue to grow. With solid return-on-equity, modest leverage and recent revenue growth, there's a tactical opportunity to buy a rebound in the mid term while keeping a tight st…
Alphabet is well positioned to lead in AGI because it owns critical assets — massive datacenters, custom silicon, DeepMind/Gemini IP and an advertising engine to monetize breakthroughs. Heavy, targeted CapEx is a deliberate strategy to secure compute advantage; this trade buys a pullback while accepting short-term earnings pressure for a multi-quar…
Xcel Energy looks positioned to capture outsized growth from accelerating electricity demand in Texas and New Mexico driven by large data-center projects and grid modernization spending. The company’s $60 billion capital plan through 2030, a ~3.0% yield, and a reasonable valuation (market cap ~$48.2B; P/E ~21x) create an asymmetric risk-reward for …
ExlService is repositioning from a services-focused IT vendor into a higher-margin data and analytics compounder. With $275M in free cash flow, a 28.9% return on equity and recent product wins in GenAI and life-insurance automation, the stock looks mispriced relative to its cash generation and growth trajectory. This trade targets a re-rating-drive…
TeraWulf's pivot from spot-bitcoin mining to long-term AI hosting is real revenue re-rating fuel. A 20-year, $19 billion Anthropic lease and a 401 MW Kentucky campus materially raise revenue visibility; the stock trades well below its 52-week high and carries heavy short interest. This trade targets a sustained recovery as capacity ramps and AI hos…
Robinhood is showing the technical and catalyst-driven signs of a constructive setup: bullish MACD, rising EMAs, and renewed optimism around crypto and tokenization. Fundamentals still command a premium - market cap ≈ $98.7B, P/E ~48, thin free cash flow relative to valuation - so I prefer to wait for a measured entry. Trade plan given below balanc…
Electromed (ELMD) is a cash-generative, niche medical-device company whose SmartVest airway clearance system remains underappreciated by the market. The shares are oversold (RSI ~20.6), float is tight and short interest has been elevated — creating a contrarian entry opportunity. We propose a mid-term (45 trading days) swing trade: buy at $30.00, s…
Comcast (CMCSA) has traded like a legacy media company for most of the last decade. Today it offers a roughly $94B market cap, a >$20B free cash flow stream and a dividend yield near 5% while trading at single-digit earnings multiples and depressed multiples vs. history. With solid cash generation, improving technicals and a valuation that already …
Ambarella has pivoted from a niche vision-chip provider into a broader edge AI platform play. Strong fiscal 2026 revenue growth, rising share of AI-focused chips, institutional accumulation and recent analyst upgrades create a favorable risk-reward. This trade targets a move back toward the 52-week highs as adoption in surveillance, automotive and …
Meta once again delivered results that reinforce its ad dominance and AI monetization runway. With a $1.45T market cap, 21x earnings and $41B in free cash flow, the setup favors accumulation on pullbacks. We lay out an actionable trade: entry $565.00, stop $525.00, target $700.00 over a 180 trading day horizon.
Callaway (ELY) combines a strong brand, recurring consumables revenue and improving direct-to-consumer channels. Recent weakness has pushed the stock to a valuation that understates cyclical recovery potential. This trade targets a rebound driven by product cadence, margin expansion and modest multiple re-rating.
AXA looks positioned to outperform over the next 45 trading days as underwriting profits normalize, investment income benefits from higher rates, and the balance sheet remains capital-robust enough to support buybacks and dividends. This trade idea outlines a mid-term long entry with concrete risk controls and clear catalysts to watch.
Elastic reported accelerating revenue and cloud adoption that undercuts the narrative of a broad SaaS slowdown. Q1 FY2026 results showed revenue of $478.11M (+15.1% YoY) with Elastic Cloud up 20.1%. Valuation sits at a midteens earnings multiple and EV/Sales near 4.9, leaving room for upside if cloud traction and margins continue to improve. This i…
International Bancshares (IBOC) trades at a reasonable valuation with high free cash flow, low leverage and solid returns - a setup that supports a long trade targeting the 52-week high. The bank's asset-quality posture and capacity to generate free cash flow justify upside while the technicals show an oversold entry.
Apollo has the balance sheet and deal flow to turn recent asset-gathering and financing platforms into sustained fee-related earnings. With market cap near $78.8B, strong free cash flow and a cleaner capital structure after a preferred conversion, the stock is set up for a rerating if realized performance fees and AUM mix shift in favor of recurrin…
Amprius (AMPX) has fallen from a $24 high to the low-$10s despite stronger production signaling and a cleaner path to defense contracts. The stock now trades at a market cap of about $1.54B with stretched valuation metrics but improving fundamentals. This trade idea outlines a disciplined long with an entry at $10.50, stop at $7.00, and target at $…
INmune Bio (INMB) is a small-cap biotech where recent signs of UK regulatory alignment for the CORDStrom platform, plus continued positive readouts and FDA Fast Track for XPro1595 in Alzheimer’s, create a defined asymmetric trade. The balance sheet is tight, but the risk/reward supports a long trade sized for high volatility.
